Abstract

BackgroundWhile progress has been made in the elimination of lymphatic filariasis, challenges that call for innovative approaches remain. Program challenges are increasingly observed in ‘hard-to-reach’ populations: urban dwellers, migrant populations, those living in insecurity, children who are out of school and areas where infrastructure is weak and education levels are low. ‘Business-as-usual’ approaches are unlikely to work. Tailored solutions are needed if elimination goals are to be reached. This article focuses on mass drug administrations (MDAs) in urban settings.MethodsWe selected the urban poor area of Santo Domingo, Dominican Republic. With three rounds of MDA and with good coverage, elimination was achieved. We wanted to understand contributing factors to achieving good coverage. A qualitative study analyzed context, barriers and facilitators using a predefined framework based on review of the literature.ResultsResults show that barriers commonly reported in urban settings were present (population density, lack of organization in household layout, population mobility, violence, shortage of human resources and challenges in monitoring treatment coverage). Tactics used included strong visibility in the community leading to high levels of awareness, the use of laminated photo sheets during house-to-house visits and a 1:4 supervision strategy. The importance of working through community leadership structures and building relationships with the community was evident.DiscussionThe approach developed here has applications for large-scale treatment programs for lymphatic filariasis and other diseases in urban settings.

Highlights

  • Lymphatic filariasis (LF) almost exclusively affects the poorest people worldwide and is one of the world’s most debilitating parasitic diseases

  • This research is set in an urban poor sector of Santo Domingo, Dominican Republic, divided into three sectors—Los Guandules, Guachupita and La Ciénaga—with a total population of 50 000 (Figure 1)

  • The challenge that we address in this article is how to obtain high treatment coverage in urban settings

Read more

Summary

Introduction

Lymphatic filariasis (LF) almost exclusively affects the poorest people worldwide and is one of the world’s most debilitating parasitic diseases. A further 80 million, while often suffering from hidden internal damage to the renal and lymphatic systems, have no external signs of disease.[1,2] LF causes mental health complications that reach far beyond its epidemiologic morbidity. While progress has been made in the elimination of lymphatic filariasis, challenges that call for innovative approaches remain. Program challenges are increasingly observed in ‘hard-to-reach’ populations: urban dwellers, migrant populations, those living in insecurity, children who are out of school and areas where infrastructure is weak and education levels are low. This article focuses on mass drug administrations (MDAs) in urban settings

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call